Roflumilast Catalog No.:M8517-10 9 nM in MDA-MB-231 cells
Pay in 4 interest-free payments of $20.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Live Spec
Roflumilast Catalog No.:M8517-10 9 nM in MDA-MB-231 cellsRoflumilast is a drug which acts as a selective, long acting inhibitor of the enzyme PDE 4. It has anti inflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such as asthma, and chronic obstructive pulmonary disease (COPD). In June 2010, Daxas was approved in the EU for severe COPD associated with chronic bronchitis.[9] In March 2011, Daliresp gained FDA approval in the
Store: live-language.pl · Domain: live-language.pl

























